The short version of Certificate of analysis fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-18 and is reviewed periodically as new material appears.
Identity and purity of NMN are commonly assessed by liquid chromatography with ultraviolet detection or mass spectrometry. High-performance liquid chromatography can separate related impurities such as nicotinamide, nicotinamide riboside, and NAD+ depending on the method. Mass spectrometry provides molecular mass confirmation, while nuclear magnetic resonance spectroscopy helps establish structure and anomeric form. Quantitative assays often use calibration curves and, in biological samples, stable isotope-labeled internal standards. Method validation addresses specificity, linearity, accuracy, precision, and limits of detection.
Quality control for NMN materials typically includes appearance, assay, impurity profile, residual solvents, heavy metals, and microbial limits. A certificate of analysis summarizes specified tests, but the underlying methods and laboratory accreditation matter. Regulatory treatment varies by country; NMN is sold as a dietary supplement in some markets, while other jurisdictions restrict its use in foods or classify it differently. Independent verification can reduce risks of mislabeling or substitution. Questions remain about how product purity, storage history, and formulation affect delivered dose in humans.
Nicotinamide mononucleotide, abbreviated NMN, is a nucleotide composed of nicotinamide, ribose, and phosphate. Its structure links nicotinamide to D-ribose 5-phosphate through a glycosidic bond, placing it in the pyridine nucleotide family. The compound exists in alpha and beta anomeric forms, and the beta form is the one used in NAD+ biosynthesis. NMN is not a protein or a hormone; it is a small water-soluble molecule that occurs in living cells as a metabolic intermediate.
Natural sources of NMN include mammals, plants, and microorganisms, where it functions as an intermediate in NAD+ salvage and biosynthesis pathways. In mammals, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferase. Some foods contain measurable NMN, but reported amounts vary widely by species, tissue, and analytical method. The extent to which dietary NMN contributes to cellular NAD+ pools remains an open research question.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual description varies by grade |
| Solubility class | Freely soluble in water | Polar nucleotide; less soluble in organic solvents |
| Typical storage temperature | -20°C or below | Protect from moisture and light; desiccated |
| Common analytical method | HPLC-UV or LC-MS | Used for identity and purity; NMR for structure |
| Hygroscopicity | Hygroscopic | Absorbs moisture; keep sealed |
Regulatory treatment varies by country. In the United States, NMN has been marketed as a dietary supplement, but the Food and Drug Administration has stated that it is excluded from the dietary supplement definition because it was authorized for investigation as a new drug before being marketed as a supplement. Other jurisdictions may treat it as a novel food, a supplement, or an unapproved drug ingredient. Import and sale rules can therefore differ substantially.
Quality control for NMN focuses on identity, purity, residual solvents, heavy metals, and microbial limits. Because the molecule can absorb water, moisture content and packaging are relevant to shelf life. Suppliers may provide certificates of analysis, but independent verification is often needed for research or commercial use. The long-term stability of different crystal forms, salt forms, and formulations is not fully characterized in the public literature. Some degradation products and their effects on product performance remain open questions.
As a commercial ingredient, nicotinamide mononucleotide is commonly supplied as a powder or capsule. Its stability depends on temperature, moisture, pH, and light exposure. Hydrolytic and thermal degradation can increase over time, so manufacturers and laboratories often store material cold and dry. Purity is typically assessed with chromatographic methods, and identity can be confirmed by mass spectrometry. Published stability data for specific finished products remain limited. More data would help define shelf life under real-world conditions.
Small amounts of NMN occur in some foods, including certain vegetables, fruits, and animal products, though the quantities are generally low and variable. Human cells also synthesize NMN internally from nicotinamide and other precursors. Research interest increased after studies examined whether raising NAD+ levels affects metabolism and aging-related pathways in animals. Evidence in humans remains limited and mixed for many outcomes, and questions about effective absorption, tissue delivery, and long-term effects are still open. Regulatory status differs by country, with some markets treating NMN as a supplement ingredient and others restricting its sale.
Nicotinamide mononucleotide, usually shortened to NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide base linked to a ribose sugar that carries a phosphate group. In cells, NMN serves as an intermediate in the salvage pathway that produces nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in many oxidation-reduction reactions, NMN sits near central metabolic processes. The compound is not a drug in most jurisdictions and is discussed mainly in biochemistry and nutrition research.
The term NMN commonly refers to the beta isomer, in which the nicotinamide group is attached to the ribose through a beta-glycosidic bond. Commercial material may be supplied as the free acid or as a salt, such as a sodium salt, which affects molecular weight and water solubility. Related compounds include nicotinamide riboside and NAD+ itself, but these are distinct molecules with different formulas and cellular handling. Laboratory research often uses the beta form because it matches the naturally occurring configuration found in biological systems.
Regulatory treatment of NMN differs by country and has changed over time. In the United States, the Food and Drug Administration has stated that NMN is excluded from the definition of a dietary supplement because it was investigated as a drug before being marketed as a supplement; enforcement and legal interpretation continue to evolve. In the European Union, NMN may require authorization as a novel food before sale. In Japan, NMN has been marketed in some food products, while it is not approved as a therapeutic drug in major markets. These categories affect labeling, permitted claims, and quality oversight.
Solid NMN is generally handled as a moisture-sensitive and light-sensitive material. Suppliers commonly recommend storage at minus 20 degrees Celsius in a sealed, desiccated container, protected from light. Aqueous solutions are less stable than the solid and may degrade faster at elevated temperatures or extreme pH values. Because NMN contains a phosphate ester and a glycosidic bond, hydrolysis and other degradation pathways are plausible under unfavorable conditions. Stability data from independent laboratories remain limited, so handling recommendations often reflect supplier practice rather than published consensus.
The human body's immune response to a surgically-implanted foreign object (prosthetic breast, cardiac pacemaker, orthopedic prosthesis) is to biologically isolate the foreign object with a capsule of tightly-woven collagen fibres. Afterwards, the capsular contracture occurs over time when the thickened, collagen-fibre capsule has compressed inwards, against the breast-implant with great mechanical pressure that deforms and breaks the implant, and so disfigures the breast; the causes of capsular contracture include bacterial contamination, shell-rupture of the medical device, leakage of the prosthetic filler-material, and hematoma. The prosthetic-breast implantation surgeries that have a low-rate of capsular contractures include surgical approaches that feature the submuscular emplacement of the breast-implant and the use of breast implants with a textured surface; limited handling of the breast implants before the surgery, limited contact with and handling of the skin of the implant-pocket, and irrigation of the surgical site with antibiotic solutions. To correct a capsular contraction, the plastic surgeon realises an open capsulotomy procedure to loosen and release the collagen-fibre capsule from the implant-pocket, for removal and replacement with a new model of prosthetic breast. Moreover, non-surgical therapies for treating collagen-fibre capsules include massage, external ultrasonic therapy, pharmaceutic therapy with leukotriene pathway inhibitor medications, and Diapulse therapy (Pulsed Electromagnetic Field Therapy, PEMFT).
haemoglobin F (foetal haemoglobin, HbF), consisting of two alpha (α-globin) and two gamma (γ-globin) chains. This dominates during foetal development and until about 6 weeks of age. Afterwards, haemoglobin A remains dominant throughout life. haemoglobin A (adult haemoglobin, HbA), which consists of two alpha and two beta (β-globin) chains. This is the most common human haemoglobin tetramer, accounting for over 97% of the total red blood cell haemoglobin in normal adults. Haemoglobin B2 (HbA2) is a second form of adult haemoglobin and is composed of two alpha and two delta (δ-globin) chains. This haemoglobin typically comprises 1–3% of haemoglobin in adults. β-globin is encoded by the HBB gene on human chromosome 11; mutations in this gene produce variants of the protein which are implicated with abnormal hemoglobins. The mutation that causes sickle cell disease results in an abnormal haemoglobin known as haemoglobin S (HbS), which replaces HbA in adults. The human genome contains a pair of genes for β-globin; in people with sickle cell disease, both genes are affected, and the erythropoietic cells in the bone marrow will only create HbS. In people with sickle cell trait, only one gene is abnormal; erythropoiesis generates a mixture of normal HbA and sickle HbS. The person has very few, if any, symptoms of sickle cell disease but carries the gene and can pass it on to their children. Sickle cell disease has an autosomal recessive pattern of inheritance.
Some researchers have noted that science, limited in that age to some early ideas about astronomy (or cosmology), had limited impact on Paleolithic technology. Making fire was widespread knowledge, and it was possible without an understanding of chemical processes. These types of practical skills are sometimes called crafts. Religion, superstitution or appeals to the supernatural may have played a part in the cultural explanations of phenomena like combustion.
Sources: en.wikipedia.org
A post hoc analysis from a randomized, placebo-controlled, multi-centre study carried out at 11 secondary care centres, as well as a longitudinal single-centre study on pregnant women in Norway, also determined that metformin had no effect on maternal androgens in pregnancies occurring in the setting of PMOS. One systemic review suggested that polymorphisms in the vitamin D receptor gene are associated with the prognosis of polyendocrine metabolic ovarian syndrome, though this is based on small sample sizes and is debated. Studies have shown benefits for vitamin D supplementation in women with vitamin D deficiency and PMOS. Hyperinsulinemia can increase the production of androgens in the ovaries. One context in which this occurs is HAIR-AN syndrome, a rare subtype of PMOS.
Effective vaccines for Haemophilus influenzae serotype b have been available since the early 1990s, and are recommended for children under age 5 and asplenic patients. The World Health Organization recommends a pentavalent vaccine, combining vaccines against diphtheria, tetanus, pertussis, hepatitis B and Hib. There is not yet sufficient evidence on how effective this pentavalent vaccine is in relation to the individual vaccines. Hib vaccines cost about seven times the total cost of vaccines against measles, polio, tuberculosis, diphtheria, tetanus, and pertussis. Consequently, whereas 92% of the populations of developed countries, 94% for European countries, were vaccinated against Hib as of 2023, vaccination coverage was 77% globally, and only 33% for people living in the western pacific region. The Hib vaccines do not provide cross-protection to any other H. influenzae serotypes like Hia, Hic, Hid, Hie or Hif. An oral vaccination has been developed for non-typeable H. influenzae (NTHi) for patients with chronic bronchitis, but it has not shown to be effective in reducing the number and severity of COPD exacerbations. However, there is no effective vaccine for the other types of capsulated H. influenzae or NTHi. Vaccines that target unencapsulated H. influenzae serotypes are in development. By 2026, following the decline of vaccinations in the United States, Hib was confirmed to be making a comeback in the country.
Christopher Cantelmo (June 19, 1962 – November 24, 2019) was an American biochemist. In 2019 he became known on Reddit under the username u/ChrisCGC for spending large sums on awards while promoting the use of DMT. The online activity around his posts was sometimes referred to as Cantelmoism.
Lee, Nick; Bessho, Yoshitaka; Wei, Kenneth; Szostak, Jack W.; Suga, Hiroaki (2000). "Ribozyme-catalyzed tRNA aminoacylation". Nature Structural Biology. 7 (1): 28–33. doi:10.1038/71225. PMID 10625423. S2CID 1831912. Ramaswamy, Krishna; Saito, Hirohide; Murakami, Hiroshi; Shiba, Kiyotaka; Suga, Hiroaki (2004). "Designer Ribozymes: Programming the tRNA Specificity into Flexizyme". Journal of the American Chemical Society. 126 (37): 11454–11455. Bibcode:2004JAChS.12611454R. doi:10.1021/ja046843y. PMID 15366888. Passioura, Toby; Suga, Hiroaki (2017). "A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targets". Chemical Communications. 53 (12): 1931–1940. doi:10.1039/C6CC06951G. PMID 28091672.
Sources: en.wikipedia.org
1993/2854) Birmingham City Council (Grand Union Canal Bridge) Scheme 1992 Confirmation Instrument 1993 (S.I. 1993/2855) Mid Essex Community and Mental Health National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2856) Wigan and Leigh Health Services National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2857) Public Airport Companies (Capital Finance) (Fourth Amendment) Order 1993 (S.I. 1993/2875) Conservation of Seals (England) Order 1993 (S.I. 1993/2876) Motor Vehicles Tyres (Safety) (Amendment) Regulations 1993 (S.I. 1993/2877) Local Government Reorganisation (Capital Money) (Greater London) (Amendment) Order 1993 (S.I. 1993/2878) Redbridge and Waltham Forest (London Borough Boundaries) Order 1993 (S.I. 1993/2881) Local Government (Compensation for Premature Retirement) (Amendment) Regulations 1993 (S.I. 1993/2890) Local Government Act 1988 (Defined Activities) (Exemption) (Wales) (No. 2) Order 1993 (S.I. 1993/2894) Protection of Wrecks (Designation No. 3) Order 1993 (S.I. 1993/2895) Community Health Sheffield National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2896) Public Telecommunication System Designation (Scottish Power Telecommunications Limited) Order 1993 (S.I. 1993/2897) Public Telecommunication System Designation (Torch Communications Limited) Order 1993 (S.I. 1993/2898) Public Telecommunication System Designation (MFS Communications Limited) Order 1993 (S.I. 1993/2899)
=== Managing warfarin therapy === Warfarin is an anticoagulant drug. It functions by inhibiting an enzyme that is responsible for recycling vitamin K to a functional state. As a consequence, proteins that should be modified by vitamin K are not, including proteins essential to blood clotting, and are thus not functional. The purpose of the drug is to reduce risk of inappropriate blood clotting, which can have serious, potentially fatal consequences. The proper anticoagulant action of warfarin is a function of vitamin K intake and drug dose. Due to differing absorption of the drug and amounts of vitamin K in the diet, dosing must be monitored and customized for each patient. Some foods are so high in vitamin K1 that medical advice is to avoid those (examples: collard greens, spinach, turnip greens) entirely, and for foods with a modestly high vitamin content, keep consumption as consistent as possible, so that the combination of vitamin intake and warfarin keep the anti-clotting activity in the therapeutic range. Vitamin K is a treatment for bleeding events caused by overdose of the drug. The vitamin can be administered by mouth, intravenously or subcutaneously. Oral vitamin K is used in situations when a person's International normalized ratio is greater than 10 but there is no active bleeding. The newer anticoagulants apixaban, dabigatran and rivaroxaban are not vitamin K antagonists.
=== Binding with MHC class II === HLA-DM catalyzes peptide exchange through binding at the beta chain of MHC class II molecules, which alters the conformation of the MHC and its peptide-binding groove. HLA-DM conformation stays constant. When a peptide is bound to the P1 locus in the peptide binding groove, it is stably bound. This also hinders HLA-DM binding to the MHC, preventing destabilization of the peptide-MHC interaction. Peptides also bind to the C-terminal site of the binding groove, but in this case the binding is a weak association, leaving the N-terminal of the groove open. HLA-DM can then bind to the N-terminal and allowing for peptide exchange.
Anatomy, In Our Time. BBC Radio 4. Melvyn Bragg with guests Ruth Richardson, Andrew Cunningham and Harold Ellis. "Anatomy of the Human Body". 20th edition. 1918. Henry Gray Parsons, Frederick Gymer (1911). "Anatomy" . Encyclopædia Britannica. Vol. 1 (11th ed.). pp. 920–943. Anatomia Collection: anatomical plates 1522 to 1867 (digitized books and images) Lyman, Henry Munson. The Book of Health (1898). Science History Institute Digital Collections Archived 2 February 2019 at the Wayback Machine. Gunther von Hagens True Anatomy for New Ways of Teaching.
=== Size preferences among sexual partners === In a 1994 cover story by Psychology Today, 1,500 readers (about two-thirds women) were surveyed about male body image. Many of the women were not particularly concerned with penis size, and over 71% thought men overemphasized the importance of penis size and shape. Generally, the women polled cared more about width than men thought, and less about length than men thought, although the strength of preference for either among women showed a similar pattern. A small study of 50 undergraduate women, surveyed by two popular male athletes on campus about their perceptions of sexual satisfaction; found the width of a penis feels better than the length of a penis, when subjects are asked to choose between the two (size was left unspecified). It was also concluded that this may show that penis size overall affects sexual satisfaction, since women chose between the two options they were given. A 2002 study at Groningen University Hospital, asked 375 sexually active women (who had recently given birth) the importance of penis size. The results showed that 21% of women thought length was important and 32% thought that girth was important. A 2013 study conducted at the Australian National University, showed that penis size influences a man's sex appeal, and the taller the man, the bigger the effect. The study showed life-sized 3D computer-generated images, altering the height and other physical attributes, with women typically registering preferences in under 3 seconds. A preference for taller men's larger penis size was indicated.
Sources: en.wikipedia.org
Solid NMN is often stored frozen, desiccated, and protected from light. Aqueous solutions are less stable and generally require colder storage or fresh preparation.
Mass spectrometry and nuclear magnetic resonance spectroscopy are used for structural confirmation. Liquid chromatography with ultraviolet or mass spectrometric detection is common for purity and quantity.
No. Chemical purity indicates the material matches specification; it does not demonstrate absorption, biological activity, or clinical benefit. Those questions require controlled human studies.
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide and an intermediate in NAD+ biosynthesis.